{"id":"https://openalex.org/W1984668488","doi":"https://doi.org/10.1097/00004714-200104000-00013","title":"In Vivo Extrastriatal and Striatal D2 Dopamine Receptor Blockade by Amisulpride in Schizophrenia","display_name":"In Vivo Extrastriatal and Striatal D2 Dopamine Receptor Blockade by Amisulpride in Schizophrenia","alternate_titles":[],"publication_year":2001,"publication_date":"2001-04-01","ids":{"openalex":"https://openalex.org/W1984668488","doi":"https://doi.org/10.1097/00004714-200104000-00013","mag":"1984668488","pmid":"https://pubmed.ncbi.nlm.nih.gov/11270918"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-200104000-00013","doi":"https://doi.org/10.1097/00004714-200104000-00013","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-200104000-00013","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1984668488"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047350595","display_name":"X. Xiberas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Xavier Xiberas","raw_affiliation_strings":["INSERM U334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay, France","INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131"]},{"raw_affiliation_string":"INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111752970","display_name":"J. L. Martinot","orcid":"https://orcid.org/0000-0002-0136-0388","observed_orcids":["https://orcid.org/0000-0002-0136-0388"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jean-Luc Martinot","raw_affiliation_strings":["INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay","Sanofi-Synth\u00e9labo, Chilly-Mazarin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131"]},{"raw_affiliation_string":"Sanofi-Synth\u00e9labo, Chilly-Mazarin","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047065171","display_name":"Luc Mallet","orcid":"https://orcid.org/0000-0001-8061-1167","observed_orcids":["https://orcid.org/0000-0001-8061-1167"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Luc Mallet","raw_affiliation_strings":["INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay","Sanofi-Synth\u00e9labo, Chilly-Mazarin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131"]},{"raw_affiliation_string":"Sanofi-Synth\u00e9labo, Chilly-Mazarin","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085832913","display_name":"\u00c9ric Artiges","orcid":"https://orcid.org/0000-0003-4461-7646","observed_orcids":["https://orcid.org/0000-0003-4461-7646"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Eric Artiges","raw_affiliation_strings":["INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108401297","display_name":"Muriel Canal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Muriel Canal","raw_affiliation_strings":["Sanofi-Synth\u00e9labo, Chilly-Mazarin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi-Synth\u00e9labo, Chilly-Mazarin","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002535442","display_name":"Christian Loc\u2019h","orcid":"https://orcid.org/0000-0003-4873-7813","observed_orcids":["https://orcid.org/0000-0003-4873-7813"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Christian Loc'h","raw_affiliation_strings":["INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002676507","display_name":"Bernard Maziere","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Bernard Mazi\u00e8re","raw_affiliation_strings":["INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029387054","display_name":"Marie\u2010Laure Paill\u00e8re Martinot","orcid":"https://orcid.org/0000-0002-0452-2450","observed_orcids":["https://orcid.org/0000-0002-0452-2450"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Marie-Laure Paill\u00e8re-Martinot","raw_affiliation_strings":["INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay","Sanofi-Synth\u00e9labo, Chilly-Mazarin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U 334, Service Hospitalier Fr\u00e9d\u00e9ric Joliot, DSV-DRM-CEA, Orsay","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131"]},{"raw_affiliation_string":"Sanofi-Synth\u00e9labo, Chilly-Mazarin","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5002535442","https://openalex.org/A5002676507","https://openalex.org/A5029387054","https://openalex.org/A5047065171","https://openalex.org/A5047350595","https://openalex.org/A5085832913","https://openalex.org/A5111752970"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131"],"apc_list":null,"apc_paid":null,"fwci":6.7083,"has_fulltext":false,"cited_by_count":100,"citation_normalized_percentile":{"value":0.97329069,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"21","issue":"2","first_page":"207","last_page":"214"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amisulpride","display_name":"amisulpride","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.7749999761581421},{"id":"https://openalex.org/keywords/dopamine-d3-receptor","display_name":"dopamine D3 receptor","score":0.8529999852180481},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9350000023841858},{"id":"https://openalex.org/keywords/striatal-dopamine-receptors","display_name":"striatal dopamine receptors","score":0.9300000071525574},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.6370000243186951},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.5699999928474426},{"id":"https://openalex.org/keywords/positive-symptoms","display_name":"positive symptoms","score":0.9660000205039978}],"concepts":[{"id":"https://openalex.org/C2778999636","wikidata":"https://www.wikidata.org/wiki/Q418785","display_name":"Amisulpride","level":4,"score":0.9805338978767395},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.7044258713722229},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5492196679115295},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5407038331031799},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5130666494369507},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.508548378944397},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.47945132851600647},{"id":"https://openalex.org/C199596767","wikidata":"https://www.wikidata.org/wiki/Q21110872","display_name":"Dopamine receptor D3","level":4,"score":0.45614075660705566},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.440424382686615},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42060238122940063},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4190330505371094},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4003921449184418},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3770916759967804},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.335978627204895},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29545342922210693},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1028202474117279}],"mesh":[{"descriptor_ui":"D000077582","descriptor_name":"Amisulpride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012457","descriptor_name":"Salicylamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013702","descriptor_name":"Temporal Lobe","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013788","descriptor_name":"Thalamus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014055","descriptor_name":"Tomography, Emission-Computed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018709","descriptor_name":"Statistics, Nonparametric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065127","descriptor_name":"Dopamine D2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-200104000-00013","doi":"https://doi.org/10.1097/00004714-200104000-00013","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-200104000-00013","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:11270918","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11270918","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W140807523","https://openalex.org/W1863821458","https://openalex.org/W1960419524","https://openalex.org/W1966092598","https://openalex.org/W1974824465","https://openalex.org/W1983200793","https://openalex.org/W1984229889","https://openalex.org/W1985050254","https://openalex.org/W1987563992","https://openalex.org/W1991263244","https://openalex.org/W2004665631","https://openalex.org/W2020267896","https://openalex.org/W2032048160","https://openalex.org/W2047458453","https://openalex.org/W2061417149","https://openalex.org/W2066883358","https://openalex.org/W2070992418","https://openalex.org/W2072069319","https://openalex.org/W2088558696","https://openalex.org/W2088637487","https://openalex.org/W2092416470","https://openalex.org/W2092636839","https://openalex.org/W2097126175","https://openalex.org/W2100828552","https://openalex.org/W2155847604","https://openalex.org/W2221911915","https://openalex.org/W2307484198","https://openalex.org/W2336055336","https://openalex.org/W2395774904","https://openalex.org/W2411826586"],"related_works":["https://openalex.org/W2017421170","https://openalex.org/W2032048160","https://openalex.org/W2188891305","https://openalex.org/W2170640771","https://openalex.org/W2324582339","https://openalex.org/W2068320698","https://openalex.org/W1960419524","https://openalex.org/W2085752551","https://openalex.org/W2105092774"],"abstract_inverted_index":{"Amisulpride,":[0],"a":[1,76,94,143],"substituted":[2],"benzamide":[3],"with":[4,62,70,73,114],"high":[5],"affinity":[6],"for":[7,155,210],"dopamine":[8,60,103],"D2":[9,59,100,194],"and":[10,24,54,57,101,132,168,184,198,203,212],"D3":[11,102],"receptors":[12,61,195],"only,":[13],"has":[14],"been":[15],"reported":[16],"to":[17,44,50,64,116,193],"have":[18],"therapeutic":[19,205],"effects":[20],"on":[21],"both":[22,181],"negative":[23,211],"positive":[25,213],"schizophrenic":[26,214],"symptoms,":[27,215],"although":[28],"at":[29],"distinct":[30],"dose":[31],"ranges":[32,206],"(50-300":[33],"mg/day":[34],"vs.":[35],"400-1,200":[36],"mg/day).":[37],"The":[38,138],"purpose":[39],"of":[40,48,79,98,130,145,191,207],"this":[41],"study":[42],"was":[43,125],"investigate":[45],"the":[46,99,109,133,151],"binding":[47,157,167,180,189],"amisulpride":[49,66,74,131,192],"extrastriatal":[51,136,166,183,197],"(i.e.,":[52],"thalamus":[53],"temporal":[55],"cortex)":[56],"striatal":[58,170,185,199],"respect":[63],"plasma":[65,128,146,160,174,208],"determinations.":[67],"Ten":[68],"patients":[69],"schizophrenia":[71],"treated":[72],"over":[75],"wide":[77],"range":[78],"doses":[80],"(25-1,200":[81],"mg/day)":[82],"were":[83,89,112,201],"studied.":[84],"Positron":[85],"emission":[86],"tomography":[87],"images":[88],"acquired":[90],"by":[91],"using":[92],"76Br-FLB-457,":[93],"highly":[95],"specific":[96],"antagonist":[97],"receptors.":[104],"Binding":[105],"indexes":[106],"(BI)":[107],"in":[108,135,148,182,196],"regions":[110,200],"studied":[111],"estimated":[113],"reference":[115],"values":[117],"from":[118],"six":[119],"healthy":[120],"subjects.":[121],"A":[122],"curvilinear":[123],"relationship":[124],"demonstrated":[126],"between":[127],"concentration":[129,147],"BI":[134,139],"regions.":[137,186],"also":[140],"varied":[141],"as":[142],"function":[144],"striatum.":[149],"Furthermore,":[150],"data":[152],"provide":[153],"evidence":[154],"different":[156],"profiles:":[158],"low":[159,169],"concentrations":[161,175,209],"(28-92":[162],"ng/mL)":[163,177],"induced":[164,178],"marked":[165,179],"binding,":[171],"whereas":[172],"higher":[173],"(>153":[176],"Dose-dependent":[187],"differential":[188],"profiles":[190],"demonstrated,":[202],"two":[204],"respectively,":[216],"are":[217],"suggested.":[218]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1984668488","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
